These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 19850470

  • 1. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
    Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD.
    Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
    [Abstract] [Full Text] [Related]

  • 2. Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose.
    Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD.
    Pediatr Blood Cancer; 2010 Jul 01; 54(7):983-9. PubMed ID: 20405516
    [Abstract] [Full Text] [Related]

  • 3. Dose-related nephrotoxicity of carboplatin in children.
    English MW, Skinner R, Pearson AD, Price L, Wyllie R, Craft AW.
    Br J Cancer; 1999 Sep 01; 81(2):336-41. PubMed ID: 10496362
    [Abstract] [Full Text] [Related]

  • 4. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
    Stöhr W, Paulides M, Bielack S, Jürgens H, Koscielniak E, Rossi R, Langer T, Beck JD.
    Pediatr Blood Cancer; 2007 Feb 01; 48(2):140-7. PubMed ID: 16724313
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT, Fels LM, Franzke A, Knop S, Renn M, Maess B, Panagiotou P, Lampe H, Kanz L, Stolte H, Bokemeyer C.
    Anticancer Res; 2000 Feb 01; 20(5C):3767-73. PubMed ID: 11268452
    [Abstract] [Full Text] [Related]

  • 6. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.
    J Pediatr Hematol Oncol; 2004 Oct 01; 26(10):649-55. PubMed ID: 15454836
    [Abstract] [Full Text] [Related]

  • 7. Renal impairment and hypertension in brain tumor patients treated in childhood are mainly associated with cisplatin treatment.
    Pietilä S, Ala-Houhala M, Lenko HL, Harmoinen AP, Turjanmaa V, Mäkipernaa A.
    Pediatr Blood Cancer; 2005 Apr 01; 44(4):363-9. PubMed ID: 15586356
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children.
    Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, Gobrial M, Baruchel S, Ito S, Koren G.
    J Clin Pharmacol; 1999 May 01; 39(5):454-61. PubMed ID: 10234592
    [Abstract] [Full Text] [Related]

  • 9. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
    Stöhr W, Paulides M, Bielack S, Jürgens H, Treuner J, Rossi R, Langer T, Beck JD.
    Pediatr Blood Cancer; 2007 Apr 01; 48(4):447-52. PubMed ID: 16628552
    [Abstract] [Full Text] [Related]

  • 10. Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial.
    Benoehr P, Krueth P, Bokemeyer C, Grenz A, Osswald H, Hartmann JT.
    J Am Soc Nephrol; 2005 Feb 01; 16(2):452-8. PubMed ID: 15590762
    [Abstract] [Full Text] [Related]

  • 11. Long-term evaluation of Ifosfamide-related nephrotoxicity in children.
    Oberlin O, Fawaz O, Rey A, Niaudet P, Ridola V, Orbach D, Bergeron C, Defachelles AS, Gentet JC, Schmitt C, Rubie H, Munzer M, Plantaz D, Deville A, Minard V, Corradini N, Leverger G, de Vathaire F.
    J Clin Oncol; 2009 Nov 10; 27(32):5350-5. PubMed ID: 19826134
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].
    Montaguti M, Brandolini C, Ferri GG, Hatzopoulos S, Prete A, Pession A.
    Acta Otorhinolaryngol Ital; 2002 Feb 10; 22(1):14-8. PubMed ID: 12236007
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.